MaaT Pharma
Pr. Eric Pamer, a Donald F. Steiner Professor, Departments of Medicine, Microbiology, and Pathology and Director, Duchossois Family Institute, focuses his research on the impact of the intestinal microbiota on resistance to Vancomycin-resistant Enterococcus faecium, Clostridium difficile, and Klebsiella pneumoniae infections in patients receiving cancer treatment, with a specific focus on highly immunocompromised patients undergoing allogeneic hematopoietic stem cell transplantation.
This person is not in the org chart
This person is not in any offices
MaaT Pharma
We are a clinical stage oncology company and industry leader in microbiome restoration therapy using biotherapeutics to treat life-threatening diseases.